Pacific Biosciences of California, Inc. (PACB)
2.125
-0.04
(-2.07%)
USD |
NASDAQ |
Dec 12, 11:12
Pacific Biosciences of California Research and Development Expense (Quarterly): 26.65M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Bruker Corp. | 98.30M |
| ICU Medical, Inc. | 21.25M |
| West Pharmaceutical Services, Inc. | 17.10M |
| Clearpoint Neuro, Inc. | 3.452M |
| Intellia Therapeutics, Inc. | 92.33M |